Literature DB >> 26266128

Lymphomas in Ile-Ife, Nigeria: Immunohistochemical Characterization and Detection of Epstein-Barr virus Encoded RNA.

Ifeyinwa M Onwubuya1, Kayode A Adelusola2, Muheez A Durosinmi3, Donatus Sabageh4, Kevin N Ezike5.   

Abstract

BACKGROUND: The proper histopathological characterization of malignant lymphomas requires the use of immunohistochemistry along with other molecular pathology techniques.
MATERIALS AND METHODS: Malignant lymphomas histologically diagnosed in our hospital were reclassified according to the WHO scheme using immunohistochemistry while in-situ hybridization was performed for the detection of Epstein-Barr virus encoded RNA.
RESULTS: There were 83 cases of lymphoma. The male to female ratio was 1.9:1 while the overall mean age was 41.7 years. Non-Hodgkin lymphomas (NHL) constituted about 79.5% of cases. The majority of cases (98.8%) were B-cell lymphomas. Nine subtypes of lymphomas were identified with diffuse large B-cell lymphomas (56.4% of which were of the germinal centre type) constituting the largest group (47.0%). Intermediate and high grade subtypes were more common. The majority of cases (72.3%) were nodal lymphomas with cervical lymph node being the commonest site (48.2%). Only classical Hodgkin lymphoma (HL) (20.5%) was seen of which the mixed cellularity subtype was the most common. Epstein Barr virus (EBV) encoded ribonucleic acid was detected in 7 cases (8.4%) including 4 cases of HL, 2 cases of Burkitt lymphoma and the only case of plasmablastic lymphoma. About five cases were reclassified as non-lymphoid malignant lesions.
CONCLUSION: Immunohistochemistry is vital to the proper classification of lymphomas even in a resource poor environment. Although nine subtypes of lymphomas were identified, diffuse large B-cell lymphomas formed the largest single group. Epstein-Barr virus probably plays an important role in lymphomatogenesis in this environment. A larger multicentre study is required to prove this.

Entities:  

Keywords:  Classification; Immunohistochemistry

Year:  2015        PMID: 26266128      PMCID: PMC4525517          DOI: 10.7860/JCDR/2015/12085.6127

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.

Authors:  A Arican; D Dinçol; H Akbulut; H Onur; A Demirkazik; F Cay; F Içli
Journal:  Am J Clin Oncol       Date:  1999-12       Impact factor: 2.339

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 3.  Epidemiology of lymphomas.

Authors:  Eve Roman; Alexandra G Smith
Journal:  Histopathology       Date:  2011-01       Impact factor: 5.087

Review 4.  Meeting the challenge of hematologic malignancies in sub-Saharan Africa.

Authors:  Satish Gopal; William A Wood; Stephanie J Lee; Thomas C Shea; Kikkeri N Naresh; Peter N Kazembe; Corey Casper; Peter B Hesseling; Ronald T Mitsuyasu
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

5.  Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia.

Authors:  S C Peh
Journal:  Histopathology       Date:  2001-05       Impact factor: 5.087

6.  Lymphoma in adult Nigerians.

Authors:  K A Adelusola; K A Adeniji; G O Somotun
Journal:  West Afr J Med       Date:  2001 Apr-Jun

7.  Lymphoreticular diseases in Nigerians.

Authors:  Kayode A Adelusola; Donatus O Sabageh; Cornelius O Ukah
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

8.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

9.  Decline in the frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan, Nigeria.

Authors:  A I Ojesina; E E U Akang; K O Ojemakinde
Journal:  Ann Trop Paediatr       Date:  2002-06

Review 10.  Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.

Authors:  L de Leval; N L Harris
Journal:  Histopathology       Date:  2003-12       Impact factor: 5.087

View more
  2 in total

1.  Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Authors:  Megan J Fitzpatrick; Shahin Sayed; Zahir Moloo; Mukendi K A Kayembe; Drucilla J Roberts; Thu-Anh Pham; Liqiang Xi; Mark Raffeld; Abner Louissaint; Aliyah R Sohani
Journal:  Am J Clin Pathol       Date:  2021-06-17       Impact factor: 2.493

2.  Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein-Barr virus infection in Nigeria population.

Authors:  Ijeoma C Uzoma; Idowu A Taiwo; Massimo Granai; Gioia Di Stefano; Ester Sorrentino; Sussana Mannucci; Muheez A Durosinmi; Stefano Lazzi; Lorenzo Leoncini; Oluyemi Akinloye
Journal:  Infect Agent Cancer       Date:  2021-05-24       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.